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Abstract
Background: The spinal column is the most frequent site of bone metastases, and between 30% and 70% of 
patients with cancer will have evidence of spinal metastasis at autopsy [1,2]. The majority of metastasis occurs in 
the thoracic spine (70%) followed by the lumbar (20%) and cervical region (10%), [2-4]. The surgical treatment of the 
vertebral metastases remains a real challenge in spine surgeons. Recent advancements in surgical techniques allow 
a less aggressive approach of the patient with better results in terms of decreasing pain, improvement of the quality of 
life. We must avoid the overtreatment of terminally ill patients; some patients may survive for several years and benefit 
from surgery.
Materials and methods: The surgical techniques that we used from August 2006 to October 2011 were the 
coablation (Figures 2a,2b) associated with vertebroplasty (Figures 3a,3b) and percutaneous osteosynthesis (Figures 
4-6). Very important were the operating room set up and the surgical technique. In our clinic, in the last 5 years, were 
treated 115 patients. With vertebroplasty (Figures 3a,3b) and ablation (Figures 2a,2b) 76 patients (94 vertebrae). We 
used the percutaneous osteosynthesis (Figures 4-6) in 39 patients aged between 42 and 88 years (mean 65 years). 
Results: In both types of treatment, the postoperative elapsed were regular with early mobilization and regression 
of pain.
Conclusion: The diagnosis and treatment of spinal metastases require multidisciplinary review. The optimal 
treatment depends from a balance between the morbidity of the surgical procedure, the estimated survival time, and 
the overall quality of life. We believe that these minimally invasive techniques are certainly a viable alternative to 
“open’’ traditional spine surgery and can help in order to reduce the pain and to restore the stability.
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Background
The spinal column is the most frequent site of bone metastases and 
between 30% and 70% of patients with cancer will have evidence of 
spinal metastasis at autopsy [1,2]. The majority of metastasis occurs 
in the thoracic spine (70%) followed by the lumbar (20%) and cervical 
region (10%), [2-4]. The surgical treatment of the vertebral metastases 
remains a real challenge in spine surgeons. Recent advancements in 
surgical techniques allow a less aggressive approach of the patient 
with better results in terms of decreasing pain, improvement of the 
quality of life. Treatment must be individually tailored for each patient 
in consideration of multiple factors including bony stability, the 
compression of neural structures, tumor radio sensitivity, pain, and, 
not least, the patient’s overall prognosis. There are minimally invasive 
surgical procedures may provide immediate pain relief and improve 
fracture-related spinal deformity.
Epidemiology 
The increase in survival in many types of cancer has increased 
the incidence of symptomatic spinal metastases. The spinal column 
is the most frequent site of bone metastases, and between 30% and 
70% of patients with cancer will have evidence of spinal metastasis at 
autopsy [1,2] . The majority of metastasis occurs in the thoracic spine 
(70%) followed by the lumbar (20%) and cervical region (10%), [3-5]. 
The thoracic spine is most commonly involved in metastatic disease, 
possibly because it contains the greatest volume of bone marrow for 
receiving metastatic deposits [6]. The vertebral column is the third 
site most affected after lungs and liver [7]. The most common primary 
malignancy is prostate cancer for men, followed by lung and colon 
cancer. For women the first cause for vertebral metastases is the breast 
cancer, followed by lung and colon cancer. Vertebral metastases occur 
in all age groups, with the highest incidence between age 40 and 65 
years [8]. 
There are two types of treatment, conservative and surgical:
Conservative and pharmacological treatment of the spinal 
metastases: Include hormonal therapy, chemotherapy (antitumor 
drugs and drugs that prevent the effects of tumor), analgesic medication 
and radiation therapy. Chemotherapy can be divided into antitumor 
drugs and drugs that prevent or ameliorate the effects of tumor. 
Antitumor chemotherapy currently plays a relatively limited role in the 
treatment of spinal metastases. Radiation therapy remains the mainstay 








































Figure 1: WBB surgical staging system,1997 [9].
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therapy is first-line for most patients who present spinal metastasis may 
be used as adjunct for residual radiographic tumor. Also the therapy 
with bisphosphonates has a big importance. Bisphosphonates are 
potent inhibitors of the osteoclastic bone resorption that is associated 
with skeletal metastases. Ιf the patient cannot be subjected to surgery, 
an external contention can help him for the pain relief.
Surgical treatment of the spinal metastases: It’s very important 
the surgical staging and the preoperative prognostic score in order to 
choose the best surgical treatment. There are many surgical staging 
system like [9, figure 1,10] (Table 1).
Also, it’s well known the existence of two types of surgery, the 
“open surgery’’ and “percutaneous’’ surgery. Both types of surgery 
may be useful in the treatment of the vertebral metastasis. Recent 
advancements in surgical techniques allow a less aggressive approach 
(percutaneous surgery) of the patient with better results in terms of 
decreasing pain, improvement of the quality of life. 
Materials and Methods
We opted for the percutaneous treatment; the reasons were the 
high age, comorbidities (Table 2), multiple metastases in bone and 
visceral sites. The surgical techniques that we used were a) coablation 
(Figures 2a,2b) associated with vertebroplasty (Figures 3a,3b) and b) 
Percutaneous osteosynthesis (Figures 4-6). In our clinic, in the last 5 
years (August 2006 to October 2011), were treated 115 patients; 56 
males and 59 females (Table 3), aged between 42 and 88 years (mean 
65 years). With vertebroplasty and ablation (Figures 2,3) 76 patients 
(66.08%), (94 vertebrae). We used the Percutaneous osteosynthesis 
(Figures 4-6) in 39 patients (33.92%).
In both types of percutaneous surgery are very important the 
operating room set up and the surgical technique:
Operating room set up and surgical technique
The patient undergoes general anesthesia. Is positioned, then, lying 
prone on the bed radiolucent. With a wire kirschner and the help of 
the image intensifier will highlight the vertebrae to be treated is drawn 
on the skin, above the vertebrae, the endplates with their peduncles. 
Appropriate image of the vertebra should show the upper and lower 
vertebral limiting double profile with no visible. The pedicles should 
appear just below the limiting upper and spinous process should be 
centered between the two pedicles. In latero-lateral view constraining 
the top should look not split and the two pedicles should be completely 
overlapped, and the back wall of the vertebral body in a perfect LL 
view should not show double contour. After careful sterilization of the 
operating field, we proceed with the insertion of the trocar inside the 
right peduncle of the affected level. The fascia is incised and opened 
Advances until arrive at the midline in the anteroposterior projection 
and to the anterior third in lateral projection. Once we are sure of 
arriving at the right place, a guide wire is inserted into the cannulated 
trocar. With it you get to touch the front wall of the vertebral body. 
Then it depends on the surgical technique that you want. In the case of 
percutaneous osteosynthesis (Figures 4-6), we proceed with the milling 
and cannulated screw insertion. In the case of coablation (Figure 2a,2b) 
and vertebroplasty (Figure 2c,2d), (Figure 3) insert the instruments 
suitable to perform coablation and subsequently vertebroplasty.
Coablation and vertebroplasty: It’s a minimally invasive 
percutaneous procedure determines destruction of the lesion (with the 
help of the heat) and subsequent stability of the vertebra. Necrotizing 
tumor tissue by heat ablation optimizes cement distribution, facilitated 
by changes in tumor consistency as a result of thermal alterations 
[11]. Very useful for the patients affected by serious diseases where 
open surgery cannot be applied (Table 2). The “difficult patients’’ can 
be subjected to surgery because we have reduced surgical times, local 
anesthesia, limited blood loss. Furthermore, the absence of intra and 
postoperative complications and reduced costs of hospitalization are 
other factors. The correct surgical indications are the small painful 
lesions with pathologic fracture risk, lesions that involved the vertebral 
body [(intra-compartmental) type 1, max type 2 according to Tomita’s 
classification]. Other indications are the failure of radiation therapy, 
secondary deformities of the spine and the intractable pain unresponsive 
to chemo-radio-hormone therapy also unstable compression fracture 
that demonstrates movement at the wedge deformity. Certainly, 
percutaneous vertebroplasty (Figure 3) after coablation (Figures 
2a,2b) stabilizes the vertebrae and provides immediate pain relief. It 
has been postulated that the analgesia provided by vertebroplasty may 
derive from stabilization of microfractures, reduc tion of mechanical 
forces, and/or destruction of the nerve terminals by the cytotoxicity 
of PMMA in the cement due to vascular, chemical, and thermal forces 
[12-15]. The contraindications of the combined procedure consist 
of osteoblastic tumors, fractures with retropulsion of the fragments 
within neural foramen, spread of tumor within the epidural space, 
local infection (osteomyelitis, discitis or epidural abscess), coagulative 
disorders, pain not related to vertebral collapse, steady asymptomatic 
fractures, and tumor involvement or missing integrity of pedicles or 
joint facets [16-19]. 
Percutaneous osteosynthesis: The percutaneous osteosynthesis 
(Figures 4-6) is an alternative for the stabilization of the vertebral 
metastatic lesions in which it is expected a good response to a future 
 Scoring System 




Long-term local control Wide or marginal ExcisionPrimary Tumor Visceral mets.* Bone mets **
3




Middle term local control Marginal or Intralesional excision5
2 Moderate Growth (Kidney, Uterus, etc.) Treatable Multiple 6 Short term palliation Palliative surgery
7
4 Rapid Growth (Lung, Stomach etc.) Untreatable
8
Terminal Care Supportive care9
10
 * No visceral mets.= 0 point ** Bone mets. Including spinal mets 
Table 1. Tomita preoperative prognostic score [10].
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chemotherapy or radiotherapy. The decision for surgery was made after 
discussion with the oncological team in all cases. We have considered 
such as correct surgical indications the vertebral lesions with high risk 
of pathologic fracture, the correction of kyphotic or scoliotic curves 
secondary to pathological vertebral collapse. Also all lesions protruding 
from the vertebral body in any direction, so the spinal osteosynthesis 
acts like an internal fixation. Allow the patient to prevent bedsores 
required for long periods of time. Many times we associate the 
percutaneous osteosynthesis (Figures 4-6) with a mini decompressive 
laminectomy in order to give better pain control and allow patient’s 
mobilization. To emphasize the use of coablation (Figures 2a,2b) and 
vertebroplasty with the transpeduncolar osteosynthesis in cases that we 
considered appropriate like the small painful lesions with pathologic 
fracture risk, lesions that involved the vertebral body. 
Results
In both types of treatment, the postoperative elapsed were regular 
with early mobilization and regression of pain. The median duration 
of the operation of the patients who treated with coablation (Figures 
2a,2b) and vertebroplasty (Figures 3a,3b) was 30 minutes and the 
median blood loss was 15 milliliters. Postoperatively, all patients were 
(a) (b) (c) (d)
Figure 2: Intraoperative radiographs, (a,b): Insertion of the trocar and subsequent 
coablation. It highlights the clear halo that is formed inside the vertebral body. 
(c,d): Insertion of the cement after coablation.
(a)                      (b)
Figure 3: (a,b): Final result in ap and lateral radiographs.
(a)                                                           (b)
(c) (d) (e)
(f)                                               (g)
Figure 5: (a,b): 74 years old male patient, suffering from prostate cancer. 
Metastasis to the sixth thoracic vertebra. (c,d,e): Intraoperative images of 
percutaneous stabilization. Also note the vertebroplasty of the sixth dorsal 
vertebra, which had previously been submitted in coablation. (f,g): anteroposterior 
and lateral radiographs.
(a)                 (b)                     (c)
(d)   (e)   (f)    (g)
(i)                             (j)
Figure 6: (a,b,c) Female patient 54 years old, affected by breast cancer. 
Radiographs and MRI where we can observe the involvement of the second 
lumbar vertebra. (d,e,f,g): Intraoperative images of percutaneous stabilization. 
Also note the vertebroplasty of the second lumbar vertebra, which had previously 
been submitted in coablation. (i,j): anteroposterior and lateral radiographs
(a)               (b)              
(c)
(d)                                                                     (e)
Figure 4: 63 years old female patient suffering from colon cancer. After 4 years 
shows a strong back pain. (a): MRI showing a metastasis to the sixth thoracic 
vertebra. (b,c): Percutaneous transpedicular osteosynthesis from third to eighth 
thoracic vertebra, final radiographs in anteroposterior and lateral projections. 
(d,e) : Intraoperative images.
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allowed to walk without the use of braces. The median duration of 
hospitalization was two days. Most of the patients were discharged to an 
oncology unit for additional treatment and rehabilitation. There were 
no perioperative or immediate postoperative deaths. Forty one patients 
(35.65%) had at least one reoperation: Twenty nine (25.21%) because 
of progression of the primary disease. Twelve patients (10.43%) had 
epidural compression at a spinal level. In the patients who treated with 
percutaneous osteosynthesis (Figures 4-6), the median duration of the 
operation was 74 minutes and the median blood loss was 108 milliliters. 
The median duration of hospitalization was seven days. Most of the 
patients were discharged to an oncology unit for additional treatment 
and rehabilitation. No patients were admitted to the intensive care unit. 
There were no perioperative or immediate postoperative deaths.
Conclusion 
The diagnosis and treatment of spinal metastases require 
multidisciplinary review. The optimal treatment depends from a 
balance between the morbidity of the surgical procedure, the estimated 
survival time, and the overall quality of life. We believe that these 
minimally invasive techniques are certainly a viable alternative to 
“open’’ traditional spine surgery and can help in order to reduce the 
pain and to restore the stability. The benefits of “minimal invasive” 
surgery are reduced muscular trauma, smaller wound and by that less 
risk of wound complications, less bleeding and faster recovery which 
for this patient category could mean a longer time with improvement 
in quality of life compared to open surgery. Symptomatic patients 
deemed poor operative candidates for open surgery due to age, 
comorbidities (Table 2), metastatic burden or limited life expectancy 
may benefit from a percutaneous mini-invasive surgery. Minimally 
invasive techniques with quick pain relief can be an alternative option 
to conventional treatments [20].
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Comorbidities  Number Patients
Chronic heart failure 7
Diabetes (type I and II) 29






H. I. V 2
Chronic hepatitis 12
Crohn’s disease 1
Chronic renal failure 7
Chronic obstructive pulmonary disease 11
Table 2: Comorbidities of the patients who were treated with percutaneous 
mode.
 Primary Cancer  Males  Females
 Breast  0  18 
 Colon  11  8
 Kidney and Renal pelvis  4  2
 Lung and Bronchus  14  9
 Liver  11  7
 Urinary Bladder  3  5
 Thyroid  1  4
 Prostate  12  0
 Endometrium (Uterus)  0  6
Table 3: The primary sites of cancer and the incidence to both sexes.
